Something of this scale would be best announced to the ASX via a scientific presentation at a major conference. It would be big news if bisantrene turns out to be a clinical FTO inhibitor.
Pillar 1 - FTO (new thread), page-2803
- There are more pages in this discussion • 129 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.93 |
Change
0.175(10.0%) |
Mkt cap ! $318.4M | |||
| Open | High | Low | Value | Volume |
| $1.87 | $1.94 | $1.86 | $403.4K | 213.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1200 | $1.91 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.92 | 500 | 1 |
View Market Depth
| Last trade - 11.17am 18/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.92 |
Change
0.175 ( 10.5 %) |
||||
| Open | High | Low | Volume | ||
| $1.86 | $1.94 | $1.86 | 10275 | ||
| Last updated 11.40am 18/06/2024 ? | |||||
| RAC (ASX) Chart |
